Drug recall
Ramipril Capsules 1.25 mg, 100-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc…
FDA recall event 60648 · Class II · Lupin Pharmaceuticals Inc.
Key facts
| Event ID | 60648 |
|---|---|
| Recall numbers | D-1175-2012 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Product type | Drugs |
| Products | Ramipril Capsules 1.25 mg, 100-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited Mumbai 400 098 INDIA Code No. GO/DRUGS/654 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Subpotent; 24 month stability timepoint |
| Initiation date | Aug 17, 2011 |
| Termination date | Nov 9, 2012 |
| City | Baltimore |
| State | MD |
| Country | United States |
| FEI number | 3004097115 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports